Insider trading

Period: 120 months Stock: NEO Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

50 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

50 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

50 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

50 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
50 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
50 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

50 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
26 Nov 2021
Brown Douglas Matthew Chief Strategy Officer
Sold, plan not stated
$1.23M 33,334 at 36.85
74.1%
Sold half or more
24 Nov 2021
Brown Douglas Matthew Chief Strategy Officer
Sold, plan not stated
$1.23M 33,333 at 36.84
42.6%
23 Nov 2021
Brown Douglas Matthew Chief Strategy Officer
Sold, plan not stated
$1.24M 33,333 at 37.19
29.9%
3 Jun 2021
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$1.25M 31,107 at 40.11
15.0%
2 Jun 2021
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$6.84M 169,230 at 40.39
44.9%
25 May 2021
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$5.13M 130,604 at 39.31
46.5%
14 Dec 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.29M 25,000 at 51.67
2.4%
14 Dec 2020
Weiss Lawrence Martin Chief Medical Officer
Sold, plan not stated
$1.03M 20,200 at 51.06
16.7%
11 Dec 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.26M 25,000 at 50.52
2.4%
10 Dec 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.01M 20,000 at 50.30
1.9%
7 Dec 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$2.26M 45,658 at 49.45
4.1%
4 Dec 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$3.10M 64,394 at 48.07
5.5%
4 Dec 2020
Johnson Kevin C Director
Sold, plan not stated
$1.18M 24,683 at 47.88
44.3%
25 Nov 2020
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$3.51M 77,074 at 45.48
17.2%
24 Nov 2020
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$2.39M 52,926 at 45.19
12.5%
16 Nov 2020
VAN OORT DOUGLAS M Chairman and CEO
Sold, plan not stated
$4.23M 100,000 at 42.34
4.0%
16 Nov 2020
HIPP RAYMOND R Director
Sold, plan not stated
$2.96M 70,000 at 42.28
51.2%
Sold half or more
13 Nov 2020
VAN OORT DOUGLAS M Chairman and CEO
Sold, plan not stated
$4.94M 118,752 at 41.56
4.5%
12 Nov 2020
VAN OORT DOUGLAS M Chairman and CEO
Sold, plan not stated
$5.11M 121,248 at 42.18
5.1%
29 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$5.21M 141,049 at 36.95
10.5%
29 Sep 2020
JONES STEVEN C Director
Sold, plan not stated
$2.96M 81,000 at 36.55
45.3%
28 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.42M 38,951 at 36.34
2.8%
10 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.41M 37,991 at 37.13
2.7%
9 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$2.65M 71,583 at 36.98
4.8%
6 Aug 2020
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$3.25M 82,500 at 39.35
19.0%
30 Jul 2020
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$3.11M 81,356 at 38.17
35.4%
4 Mar 2020
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$3.03M 98,093 at 30.86
39.3%
2 Mar 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$7.21M 250,000 at 28.85
15.4%
20 Nov 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$3.12M 128,068 at 24.35
7.6%
19 Nov 2019
VAN OORT DOUGLAS M Chairman and CEO · indirect
Sold, plan not stated
$4.52M 187,500 at 24.08
100%
Sold half or more
6 Nov 2019
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$1.18M 51,556 at 22.82
14.5%
31 Oct 2019
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$1.63M 70,473 at 23.11
28.0%
26 Aug 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$3.57M 143,603 at 24.87
7.6%
23 Aug 2019
Johnson Kevin C Director
Sold, plan not stated
$1.05M 41,200 at 25.60
50.7%
Sold half or more
8 May 2019
HIPP RAYMOND R Director
Sold, plan not stated
$2.65M 118,479 at 22.36
46.3%
3 May 2019
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$3.46M 151,676 at 22.82
33.5%
2 May 2019
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated 2×
$2.64M 119,347 at 22.14
42.4%
27 Feb 2019
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$4.78M 252,881 at 18.90
11.7%
26 Feb 2019
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$2.68M 141,879 at 18.88
45.9%
26 Feb 2019
Bonello William Chief Strategy Officer
Sold, plan not stated
$1.14M 60,203 at 18.90
100%
Sold half or more
14 Dec 2018
GENERAL ELECTRIC CO Former 10% Owner · indirect
Sold, plan not stated
$130.02M 10,835,145 at 12.00
100%
Sold half or more
12 Nov 2018
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$1.67M 100,000 at 16.66
4.3%
9 Nov 2018
GENERAL ELECTRIC CO 10% owner · indirect
Sold, plan not stated
$69.76M 4,164,855 at 16.75
27.8%
9 Nov 2018
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$3.07M 180,000 at 17.05
53.0%
Sold half or more
9 Nov 2018
Johnson Kevin C Director
Sold, plan not stated 2×
$1.12M 66,007 at 17.03
45.9%
1 Aug 2018
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$1.68M 119,948 at 14.00
5.0%
22 Jun 2018
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$1.26M 89,688 at 14.04
3.5%
19 Jun 2018
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$2.11M 158,312 at 13.32
5.8%
1 Jun 2018
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$2.79M 230,533 at 12.12
7.7%
29 May 2018
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$1.33M 114,300 at 11.67
3.6%
Showing 1–50 of 50.